NeuroOne Medical Technologies Corp: Key Insights from 8-K Filing on Feb 12, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: NeuroOne Medical Technologies Corporation
- CIK (Central Index Key): 0001500198
- SEC File Number: 001-40439
- EIN (Employer Identification Number): 27-0863354
- Address: 7599 Anagram Dr., Eden Prairie, MN 55344
- Phone Number: 952-426-1383
- Filing Details:
- Form Type: 8-K (Current Report)
- Filing Date: February 12, 2025
- Stock Information:
- Security Type: Common Stock
- Par Value: $0.001 per share
- Ticker Symbol: NMTC
- Exchange: NASDAQ
- Context and Measurement:
- Reporting Date: The context indicates the report pertains to February 12, 2025.
- Currency: USD (United States Dollar)
- Measurement Units: Shares and USD per share.
- Additional Information:
- The filing is part of a larger framework (indicated by the XML schema reference), and it appears to be a standard disclosure related to the company's financial status or significant corporate events as per SEC requirements.
Insights:
- The company is publicly traded on NASDAQ under the ticker NMTC, indicating it is subjected to SEC regulations and must comply with periodic reporting requirements.
- The 8-K form suggests that this filing may involve significant events or changes that warrant immediate attention from investors, though specific details of such events are not included in this snippet.
- The company is relatively new in the market, as evidenced by the recent filing date and the nature of the information.
This analysis provides a foundational understanding of the company's current reporting status and essential identifiers for further investigation or decision-making.